Ultragenyx Pharmaceutical (RARE)
(Real Time Quote from BATS)
$44.55 USD
+0.70 (1.60%)
Updated Apr 26, 2024 10:06 AM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.73 | 5.53% |
Earnings Summary
For their last quarter, Ultragenyx Pharmaceutical (RARE) reported earnings of -$1.52 per share, beating the Zacks Consensus Estimate of $-1.65 per share. This reflects a positive earnings surprise of 7.88%. Look out for RARE's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.73 per share, reflecting a year-over-year increase of 25.75%.
Earnings History
Price & Consensus
Zacks News for RARE
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services